Director George Bickerstaff receives 9,795 RSUs at CareDx (NASDAQ: CDNA)
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Bickerstaff George reported acquisition or exercise transactions in this Form 4 filing.
CareDx, Inc. director George Bickerstaff received an equity award in the form of 9,795 shares of Common Stock represented by restricted stock units. These RSUs were granted at no cash cost to him and are part of his compensation.
The RSUs vest 100% on the earlier of the one-year anniversary of the grant date or the day immediately before the first Annual Meeting that occurs after the grant date, subject to his continuous service through that time. Following this award, he holds 154,061 shares of Common Stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
1 transaction reported
Mixed
1 txn
Insider
Bickerstaff George
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 9,795 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 154,061 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
RSU grant size: 9,795 shares
Grant price: $0.00 per share
Post-transaction holdings: 154,061 shares
+1 more
4 metrics
RSU grant size
9,795 shares
Restricted stock units representing Common Stock granted to director
Grant price
$0.00 per share
Compensation-related RSU award with no cash paid by director
Post-transaction holdings
154,061 shares
Total Common Stock held directly after the RSU grant
Vesting condition
100% cliff vesting
Earlier of one year after grant or day before first Annual Meeting
Key Terms
restricted stock units ("RSUs"), Annual Meeting, continuous service
3 terms
restricted stock units ("RSUs") financial
"The reported securities are represented by restricted stock units ("RSUs"), of which the RSUs vests 100%..."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Annual Meeting financial
"on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting..."
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
continuous service financial
"subject to the Reporting Person's continuous service on each applicable vesting date."
FAQ
What insider transaction did CareDx (CDNA) report for George Bickerstaff?
CareDx reported that director George Bickerstaff received 9,795 shares of Common Stock represented by restricted stock units. These units were granted at no cash cost and are a compensation-related equity award, increasing his directly held position to 154,061 shares after the grant.
What are the vesting terms of George Bickerstaff’s CareDx RSUs?
The reported CareDx restricted stock units vest 100% on the earlier of the one-year anniversary of the grant date or the day immediately before the first Annual Meeting after the grant date. Vesting is conditioned on Bickerstaff’s continuous service through the applicable vesting date.
What type of security did George Bickerstaff receive from CareDx?
George Bickerstaff received restricted stock units representing shares of CareDx Common Stock. Each RSU converts into Common Stock upon vesting, subject to the vesting schedule and his continuous service, effectively functioning as deferred share-based compensation rather than immediate stock delivery.